Receive Promise magazine online to learn about the innovative research and excellent medical care happening at St. Jude. Your free subscription will start with our next quarterly issue of Promise.
In this issue . . .
A Cancer Chameleon: Mixed-phenotype Acute Leukemia
Features of mixed-phenotype acute leukemia can change, enough to switch the diagnosis from one acute leukemia to the other.
Delta Dental and the Smile180 Foundation have donated $2 million to support St. Jude treatment, research and awareness.
Science Alliance: Fighting PKAN Together
Married St. Jude researchers broaden their collaboration to develop a novel medication for pantothenate kinase-associated neurodegeneration (PKAN), a life-threatening neurological disorder.
St. Jude and WHO Unite to Save Lives
The greatest predictor of survival for a child with cancer is where that child happens to live. St. Jude and World Health Organization join forces to change that sobering fact.
Flu Fighters: How the Immune System Protects Infants from Influenza
St. Jude investigators discover how guardian T cells help combat influenza in infants and young children.
Dance of the T Cells
A new therapy at St. Jude called CAR T-cell therapy holds hope for many children who have cancer that returns or is hard to treat.
Dawn of a New Era for Aggressive Brain Tumors
Relapsed brain tumors have been difficult to treat, but a new approach at St. Jude offers a ray of hope.
Cryo-EM: It’s a Small, Small World
Scientists in the new St. Jude Cryo-EM and Tomography Center zoom in on staggeringly small structures to better understand biological systems.
Touchdown, St. Jude
Football stars from Lausanne Collegiate School turn fundraising champs for the hospital by winning the 2018 Touchdowns Against Cancer national championship.
Run for a Reason
More than 26,000 runners and walkers recently laced up their shoes for the 2018 St. Jude Memphis Marathon Weekend, the largest single-day fundraising event for St. Jude.
Research Highlights - Winter 2019
Learn about whole genome sequencing; the Hippo pathway; scavenger immune cells; tumor suppressor gene SPOP; free acute leukemia models; and more.